Patents by Inventor Cecilia Eriksson

Cecilia Eriksson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9561090
    Abstract: Methods of producing a dental product are disclosed. Certain methods include the steps of providing a pre-sintered blank made from a green body of ceramic material, performing a machining operation on the blank, and subsequently sintering the blank to its final density in a sintering operation performed at a temperature in the range of 1300° C. to 1650° C. The pre-sintered blank that is provided may have a strength in the range of 53-107 MPa.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: February 7, 2017
    Assignee: Nobel Biocare Services AG
    Inventors: Cecilia Eriksson, Petrus Brännvall, Lars Jörneus, Carina Berggren
  • Patent number: 8501467
    Abstract: Cultures of cells immunoreactive for glial fibrillary acidic protein (GFAP), as well as for the intermediate filament marker nestin were grown in a medium including epidermal growth factor (EGF) and serum. The cultured cells had the morphology of astroglial cells. The cells can be proliferated in adherent or suspension cultures. Depending on the culture conditions, the cells can be induced to differentiate to neurons or glial cells. The cultures can be expanded over a large number of passages during several months, and survive, express an astroglial phenotype and integrate well after transplantation into both neonatal and adult rat forebrain.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: August 6, 2013
    Assignee: StemCells California, Inc.
    Inventors: Lars Wahlberg, Kenneth Campbell, Charlotta Skogh, Cecilia Eriksson, Klas Wictorin
  • Publication number: 20120326343
    Abstract: Methods of producing a dental product are disclosed. Certain methods include the steps of providing a pre-sintered blank made from a green body of ceramic material, performing a machining operation on the blank, and subsequently sintering the blank to its final density in a sintering operation performed at a temperature in the range of 1300° C. to 1650° C. The pre-sintered blank that is provided may have a strength in the range of 53-107 MPa.
    Type: Application
    Filed: June 26, 2012
    Publication date: December 27, 2012
    Applicant: NOBEL BIOCARE SERVICES AG
    Inventors: Cecilia Eriksson, Petrus Brãnnvall, Lars Jörneus, Carina Berggren
  • Patent number: 8231825
    Abstract: Methods of producing a dental product are disclosed. Certain methods include the steps of providing a pre-sintered blank made from a green body of ceramic material, performing a machining operation on the blank, and subsequently sintering the blank to its final density in a sintering operation performed at a temperature in the range of 1300° C. to 1650° C. The pre-sintered blank that is provided may have a strength in the range of 53-107 MPa.
    Type: Grant
    Filed: May 28, 2008
    Date of Patent: July 31, 2012
    Assignee: Nobel Biocare Services AG
    Inventors: Cecilia Eriksson, Petrus Brännvall, Lars Jörneus, Carina Berggren
  • Publication number: 20100323327
    Abstract: Methods of producing a dental product are disclosed. Certain methods include the steps of providing a pre-sintered blank made from a green body of ceramic material, performing a machining operation on the blank, and subsequently sintering the blank to its final density in a sintering operation performed at a temperature in the range of 1300° C. to 1650° C. The pre-sintered blank that is provided may have a strength in the range of 53 -107 MPa.
    Type: Application
    Filed: May 28, 2008
    Publication date: December 23, 2010
    Applicant: NOBEL BIOCARE SERVICES AG
    Inventors: Cecilia Eriksson, Petrus Brännvall, Lars Jörneus, Carina Berggren
  • Patent number: 7651853
    Abstract: Cultures of cells immunoreactive for glial fibrillary acidic protein (GFAP), as well as for the intermediate filament marker nestin were grown in a medium including epidermal growth factor (EGF) and serum. The cultured cells had the morphology of astroglial cells. The cells can be proliferated in adherent or suspension cultures. Depending on the culture conditions, the cells can be induced to differentiate to neurons or glial cells. The cultures can be expanded over a large number of passages during several months, and survive, express an astroglial phenotype and integrate well after transplantation into both neonatal and adult rat forebrain.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: January 26, 2010
    Assignee: NsGene A/S
    Inventors: Lars Wahlberg, Kenneth Campbell, Charlotta Skogh, Cecilia Eriksson, Klas Wictorin
  • Publication number: 20080138895
    Abstract: Cultures of cells immunoreactive for glial fibrillary acidic protein (GFAP), as well as for the intermediate filament marker nestin were grown in a medium including epidermal growth factor (EGF) and serum. The cultured cells had the morphology of astroglial cells. The cells can be proliferated in adherent or suspension cultures. Depending on the culture conditions, the cells can be induced to differentiate to neurons or glial cells. The cultures can be expanded over a large number of passages during several months, and survive, express an astroglial phenotype and integrate well after transplantation into both neonatal and adult rat forebrain.
    Type: Application
    Filed: October 31, 2007
    Publication date: June 12, 2008
    Inventors: Lars Wahlberg, Kenneth Campbell, Charlotta Skogh, Cecilia Eriksson, Klas Wictorin
  • Patent number: 7303912
    Abstract: Cultures of cells immunoreactive for glial fibrillary acidic protein (GFAP), as well as for the intermediate filament marker nestin were grown in a medium including epidermal growth factor (EGF) and serum. The cultured cells had the morphology of astroglial cells. The cells can be proliferated in adherent or suspension cultures. Depending on the culture conditions, the cells can be induced to differentiate to neurons or glial cells. The cultures can be expanded over a large number of passages during several months, and survive, express an astroglial phenotype and integrate well after transplantation into both neonatal and adult rat forebrain.
    Type: Grant
    Filed: February 22, 2005
    Date of Patent: December 4, 2007
    Assignee: NsGene A/S
    Inventors: Lars Wahlberg, Kenneth Campbell, Charlotta Skogh, Cecilia Eriksson, Klas Wictorin
  • Publication number: 20050191745
    Abstract: Cultures of cells immunoreactive for glial fibrillary acidic protein (GFAP), as well as for the intermediate filament marker nestin were grown in a medium including epidermal growth factor (EGF) and serum. The cultured cells had the morphology of astroglial cells. The cells can be proliferated in adherent or suspension cultures. Depending on the culture conditions, the cells can be induced to differentiate to neurons or glial cells. The cultures can be expanded over a large number of passages during several months, and survive, express an astroglial phenotype and integrate well after transplantation into both neonatal and adult rat forebrain.
    Type: Application
    Filed: February 22, 2005
    Publication date: September 1, 2005
    Inventors: Lars Wahlberg, Kenneth Campbell, Charlotta Skogh, Cecilia Eriksson, Klas Wictorin
  • Patent number: 6878543
    Abstract: Cultures of cells immunoreactive for glial fibrillary acidic protein (GFAP), as well as for the intermediate filament marker nestin were grown in a medium including epidermal growth factor (EGF) and serum. The cultured cells had the morphology of astroglial cells. The cells can be proliferated in adherent or suspension cultures. Depending on the culture conditions, the cells can be induced to differentiate to neurons or glial cells. The cultures can be expanded over a large number of passages during several months, and survive, express an astroglial phenotype and integrate well after transplantation into both neonatal and adult rat forebrain.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: April 12, 2005
    Assignee: NsGene SA
    Inventors: Lars Wahlberg, Kenneth Campbell, Charlotta Skogh, Cecilia Eriksson, Klas Wictorin